Next-generation Sequencing Library Preparation Market (2026 to 2035)

Next-generation Sequencing Library Preparation Market (2026 to 2035) Market Size, Share & Trends Analysis Report

Next-generation Sequencing Library Preparation Market Size, Market Share, Market Volume, AGR%, CAGR%, Market Share, Strategic Drivers, Trends, Opportunities, Production, Trade Analysis, Value Chain, Market Trends, By Offerings, By Application, By Technology (Platforms), By Type (Products), By Workflow (Product), By End User (Products), By Type (Services), By Workflow (Services), By End User (Services) By Geographical Regions, Competitive Analysis, Recent Activities, Patient Analysis, Clinical Trails, Consultation & Advisory Services, and more.

Published
Report ID : BMRC 3878
Number of pages : 300
Published Date : Jul 2026
Category : Healthcare
Delivery Timeline : 48 hrs

Next-generation Sequencing Library Preparation Market Summary:

The global Next-generation Sequencing Library Preparation market size was valued at USD 2145.9 million in 2025 and is projected to reach USD 8010.9 million by 2035, expanding at a CAGR of 14.08% from 2026 to 2035. Market growth is driven by expanding precision medicine, increasing genome sequencing projects, rising oncology and rare disease testing, and continuous advancements in automated library preparation technologies.

Next-generation Sequencing Library Preparation Market Revenue Forecast, 2022–2035 (US$ Million)

Years

2022

2023

2024

2025

2026

2027

2028

2029

2030

2031

2032

2033

2034

2035

Revenue (USD Mn)

1515.2

XX

XX

2145.9

XX

XX

XX

XX

XX

XX

XX

XX

XX

8010.9

Key Market Takeaways & Insights

  • North America Next-generation Sequencing Library Preparation market held the largest share of 45.1% of the global market in 2025.
  • The Next-generation Sequencing Library Preparation industry in the Asia Pacific is expected to grow significantly over the forecast period.
  • By Offerings, the Products segment held the largest market share of 74.6% in 2025.
  • By Application, the Diagnostics segment held the largest market share in 2025.
  • By Technology (Platforms), the Sequencing By Synthesis segment held the largest market share in 2025.

Market Intelligence Overview (Historical, Current, Forecast):

  • 2022 Next-generation Sequencing Library Preparation Market Size: USD 1515.2Million
  • 2025 Next-generation Sequencing Library Preparation Market Size: USD 2145.9Million
  • 2035 Next-generation Sequencing Library Preparation Market Size: USD 8010.9Million
  • CAGR (2026-2035): 14.08%

Next-generation Sequencing Library Preparation Market Regional Forecast Analysis, 2026–2035 (US$ Million)

Region

2022

2023

2024

2025

2026

2027

2028

2029

2030

2031

2032

2033

2034

2035

North America

XX

XX

XX

967.8

XX

XX

XX

XX

XX

XX

XX

XX

XX

3227.5

Europe

XX

XX

XX

536.4

XX

XX

XX

XX

XX

XX

XX

XX

XX

1870

Asia Pacific

XX

XX

XX

472

XX

XX

XX

XX

XX

XX

XX

XX

XX

2269.2

Latin America

XX

XX

XX

66.5

XX

XX

XX

XX

XX

XX

XX

XX

XX

262.1

Middle East & Africa

XX

XX

XX

103

XX

XX

XX

XX

XX

XX

XX

XX

XX

381.8

Technology & Platform Analysis:

  • Library preparation workflow evaluation
  • Automation and throughput assessment
  • Sequencing platform compatibility analysis
  • Emerging library preparation technology trends

Application & End-User Analysis :

  • Clinical and research application assessment
  • Diagnostic and drug discovery adoption trends
  • End-user utilization analysis
  • Laboratory workflow optimization evaluation

Next-generation Sequencing Library Preparation Market Outlook Analysis Conservative, Likely, Optimistic,(US$ Million), 2025–2035

 

2025

2026

2027

2028

2029

2030

2031

2032

2033

2034

2035

Conservative

2145.9

XX

XX

XX

XX

XX

XX

XX

XX

XX

7349.1

Likely

2145.9

XX

XX

XX

XX

XX

XX

XX

XX

XX

8010.9

Optimistic

2145.9

XX

XX

XX

XX

XX

XX

XX

XX

XX

12016.3

Market Dynamics:

Market Drivers:

Expanding Precision Medicine and National Genome Sequencing Initiatives Accelerating Demand for NGS Library Preparation

The rapid expansion of precision medicine programs and government-supported genome sequencing initiatives is one of the strongest growth drivers for the Next-generation Sequencing (NGS) Library Preparation Market. As healthcare systems increasingly integrate genomic information into disease diagnosis, treatment selection, and preventive medicine, the demand for high-quality library preparation kits, reagents, and automated workflows continues to rise.

Library preparation represents a critical step in NGS workflows because it directly influences sequencing accuracy, coverage, and reproducibility across oncology, rare disease, reproductive health, and infectious disease applications. Consequently, hospitals, reference laboratories, pharmaceutical companies, and research institutes are investing in advanced library preparation technologies that deliver higher throughput, reduced hands-on time, and improved data quality.

Government-funded genomics initiatives continue to strengthen this demand. According to the U.S. National Institutes of Health (NIH), the All of Us Research Program has generated genomic data from nearly 250,000 participants and identified more than 275 million previously unreported genetic variants, significantly expanding genomic resources for clinical and biomedical research. Earlier, NIH also released its first dataset containing nearly 100,000 whole genome sequences and genotyping data from 165,000 participants, creating one of the world's most diverse genomic databases.

Furthermore, the American Society of Human Genetics (ASHG) reports that the cost of sequencing a complete human genome has declined from approximately US$100 million in 2001 to around US$500 by 2024, enabling broader adoption of genome sequencing in clinical practice and research. These developments substantially increase the demand for reliable, scalable, and automation-compatible library preparation solutions capable of supporting large-volume sequencing projects and precision medicine programs worldwide.

Growing Adoption of Automated Library Preparation Technologies in Clinical and Research Laboratories

The increasing adoption of automated library preparation systems is transforming next-generation sequencing workflows across clinical diagnostics, pharmaceutical research, biotechnology companies, and academic laboratories. Manual library preparation often involves multiple complex steps, including nucleic acid fragmentation, end repair, adapter ligation, amplification, and purification, making workflows labor-intensive and susceptible to human error.

Automation significantly improves workflow standardization, minimizes sample variability, reduces contamination risks, and increases throughput, enabling laboratories to process hundreds or thousands of samples efficiently while maintaining high reproducibility. These advantages are becoming increasingly important as sequencing volumes continue to expand across oncology, infectious disease surveillance, hereditary disease testing, pharmacogenomics, and population-scale genomic studies.

Advancements in robotic liquid handling platforms, integrated sample preparation instruments, magnetic bead-based purification systems, and AI-assisted workflow optimization have further accelerated the transition toward automated library preparation. Modern solutions also support multiplexing, low-input DNA and RNA samples, single-cell sequencing, long-read sequencing, and multi-omics applications, allowing laboratories to maximize sequencing efficiency while reducing turnaround time and operational costs.

Pharmaceutical companies increasingly rely on automated library preparation to support biomarker discovery, companion diagnostic development, and clinical trial sequencing, while hospitals and diagnostic laboratories utilize automation to improve consistency in routine genomic testing. As sequencing technologies continue to evolve toward higher throughput and greater clinical adoption, the need for scalable, standardized, and automation-enabled library preparation workflows will remain a critical factor supporting sustained growth in the Next-generation Sequencing Library Preparation Market.

Market Restraint:

High Cost of NGS Library Preparation Workflows and Advanced Sequencing Infrastructure

The high cost associated with next-generation sequencing (NGS) library preparation remains a significant restraint for market growth, particularly among small and mid-sized clinical laboratories, academic institutions, and healthcare providers in developing economies. Although sequencing costs have declined substantially over the past decade, library preparation continues to account for a considerable portion of total sequencing expenses due to the need for specialized reagents, sample preparation kits, automation platforms, quality control instruments, and skilled personnel. Laboratories must also invest in laboratory information management systems (LIMS), bioinformatics software, and regulatory compliance, increasing the overall cost of ownership and limiting broader adoption.

According to the U.S. National Human Genome Research Institute (NHGRI), while the cost of producing a human whole genome sequence has declined to below US$1,000, downstream workflow expenses including library preparation, quality assessment, data storage, and bioinformatics remain substantial contributors to total testing costs. In addition, the World Health Organization (WHO) has highlighted that many low- and middle-income countries continue to face challenges in implementing NGS because of limited laboratory infrastructure, high equipment procurement costs, and dependence on imported sequencing consumables.

These financial barriers slow the adoption of advanced genomic testing outside well-funded research institutions and major healthcare centers. Consequently, laboratories often delay upgrading to automated library preparation systems or expanding sequencing capacity, restricting market penetration despite increasing demand for precision medicine and molecular diagnostics.

Limited Availability of Skilled Genomics and Bioinformatics Professionals

A persistent shortage of trained professionals capable of performing next-generation sequencing library preparation, sequencing operations, and bioinformatics analysis continues to restrain market expansion. Successful implementation of NGS requires multidisciplinary expertise in molecular biology, genomics, quality assurance, data analysis, and clinical interpretation.

Many hospitals, diagnostic laboratories, and research institutes, particularly in emerging markets, face difficulties recruiting and retaining qualified personnel, resulting in underutilization of sequencing infrastructure and slower adoption of advanced library preparation technologies. The challenge becomes even greater as laboratories transition toward automated and high-throughput sequencing workflows that require specialized technical knowledge for validation, troubleshooting, and data management.

The World Health Organization (WHO) has emphasized that strengthening workforce capacity is a critical requirement for expanding NGS implementation, noting that genomic surveillance and sequencing programs increasingly depend on trained laboratory scientists and bioinformatics specialists. Similarly, publications supported by international genomics organizations highlight that shortages in genomics education, laboratory training, and bioinformatics expertise remain major barriers to widespread adoption of sequencing technologies, particularly in resource-constrained regions.

As sequencing applications continue to expand across oncology, infectious disease surveillance, reproductive health, and precision medicine, the demand for highly skilled professionals is expected to outpace workforce development. Without sustained investments in specialized training programs, laboratory education, and bioinformatics capacity building, the shortage of qualified personnel will continue to limit the efficient deployment and scalability of NGS library preparation technologies worldwide.

Market Opportunities:

Expansion of Population-Scale Genomics and National Sequencing Programs

The rapid expansion of national genome sequencing initiatives and population-scale genomics programs presents a significant opportunity for the Next-generation Sequencing (NGS) Library Preparation Market. Governments, healthcare organizations, and research institutes are increasingly investing in large genomic databases to improve disease prevention, accelerate precision medicine, and advance biomedical research. These initiatives require standardized, high-throughput, and automation-compatible library preparation workflows capable of processing hundreds of thousands of DNA and RNA samples with high reproducibility.

As sequencing programs continue to expand, demand for advanced library preparation kits, automated sample preparation platforms, and high-quality reagents will increase substantially. Companies offering scalable, cost-effective, and automation-ready solutions are well positioned to capitalize on long-term procurement opportunities from national healthcare systems, biobanks, academic institutions, and pharmaceutical research organizations.

The U.S. National Institutes of Health (NIH) All of Us Research Program announced in February 2025 that its research dataset had expanded to include more than 633,000 participants, representing a 50% increase from the previous release. In addition, the genomic dataset now contains whole genome sequences from more than 414,000 participants, making it one of the world's largest precision medicine resources.

Such large-scale sequencing initiatives significantly increase demand for reliable library preparation technologies that enable efficient processing of diverse biological samples while maintaining sequencing accuracy and workflow consistency. Similar national genomics programs being implemented across Europe, Asia-Pacific, and the Middle East are expected to further strengthen long-term market opportunities for NGS library preparation solution providers.

Next-generation Sequencing Library Preparation Market Share Analysis by Offerings, 2025 (%)

By Offerings

2025

Products

74.6%

Services

25.4%

Next-generation Sequencing Library Preparation Market Segmentations Analysis:

By Offerings (Products, Services)

The Products segment accounted for the largest share of the Next-generation Sequencing Library Preparation Market due to the widespread use of library preparation kits, reagents, adapters, enzymes, beads, and consumables in every sequencing workflow. Continuous product innovations, increasing automation compatibility, and growing adoption of NGS in clinical diagnostics, oncology, and genomics research continue to strengthen segment dominance.

The Services segment is projected to witness the fastest growth during the forecast period, driven by increasing outsourcing of sequencing workflows to contract research organizations and specialized genomic service providers. Rising demand for cost-effective library preparation, bioinformatics support, custom sequencing services, and expanding pharmaceutical research collaborations is accelerating market growth.

By Application (Diagnostics (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Other Diagnostic Applications), Drug Discovery & Development (Pharmacogenomics, Other Drug Discovery & Development Applications), Agriculture & Animal Research, Other Applications))

The Diagnostics segment held the largest share of the Next-generation Sequencing Library Preparation Market, driven by the growing adoption of NGS in oncology, rare disease diagnosis, infectious disease detection, and reproductive health testing. Increasing implementation of precision medicine, companion diagnostics, and clinical genomic testing has significantly boosted demand for high-quality library preparation solutions.

The Drug Discovery & Development segment is expected to register the fastest growth during the forecast period due to increasing use of NGS for biomarker discovery, target identification, pharmacogenomics, and clinical trial research. Rising pharmaceutical and biotechnology R&D investments, coupled with expanding multi-omics applications, are accelerating demand for advanced library preparation technologies.

By Technology (Platforms) (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real Time Sequencing, Nanopore Sequencing, Other Sequencing Technologies)

The Sequencing By Synthesis (SBS) segment dominated the Next-generation Sequencing Library Preparation Market owing to its high sequencing accuracy, scalability, and broad adoption in clinical diagnostics, oncology, whole-genome sequencing, and transcriptomics. Strong compatibility with automated library preparation workflows and extensive use by research institutions and healthcare laboratories continue to reinforce its market leadership.

The Nanopore Sequencing segment is projected to witness the fastest growth during the forecast period, driven by increasing demand for real-time sequencing, long-read genomic analysis, portable sequencing devices, and rapid infectious disease surveillance. Continuous technological advancements and expanding applications in clinical diagnostics, environmental genomics, and field-based research are accelerating adoption.

By Type (Products) (Consumables (Library Preparation Kits & Reagents, Sequencing Kits & Reagents, Other Consumables), Platforms (Sequencing Platforms, Library Preparation Platforms), Bioinformatics Tools (Data Analysis Software & Workbenches, Data Visualization Tools, Other Bioinformatics Tools))

The Consumables segment accounted for the largest share of the Next-generation Sequencing Library Preparation Market due to the recurring demand for library preparation kits, enzymes, adapters, primers, beads, and reagents across every sequencing workflow. Continuous utilization in clinical diagnostics, pharmaceutical research, and academic genomics, coupled with frequent replenishment requirements, sustains the segment's market dominance.

The Bioinformatics Tools segment is anticipated to register the fastest growth during the forecast period, driven by increasing volumes of sequencing data and the need for efficient data processing, analysis, and interpretation. Growing adoption of AI-enabled analytics, cloud-based genomic platforms, and integrated bioinformatics solutions is accelerating demand across research and clinical laboratories.

By Workflow (Product) (Sequencing, Presequencing, Data Analysis)

The Sequencing segment held the largest share of the Next-generation Sequencing Library Preparation Market, driven by its central role in genomic workflows and widespread adoption across clinical diagnostics, oncology, rare disease testing, and biomedical research. Continuous advancements in high-throughput sequencing platforms and increasing sample volumes continue to strengthen the segment's market leadership.

The Data Analysis segment is expected to witness the fastest growth during the forecast period due to the exponential increase in genomic data generated by next-generation sequencing. Rising adoption of AI-powered bioinformatics platforms, cloud-based analytics, and precision medicine applications is driving demand for advanced data analysis solutions across clinical and research settings.

By End User (Products) (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical & Diagnostics Laboratories, Other End Users)

The Academic & Research Institutes segment accounted for the largest share of the Next-generation Sequencing Library Preparation Market, driven by extensive genomics research, government-funded sequencing projects, and increasing adoption of NGS for basic, translational, and population genomics studies. Continuous investments in research infrastructure and collaborative scientific programs further support the segment's dominance.

The Clinical & Diagnostics Laboratories segment is projected to register the fastest growth during the forecast period, fueled by increasing adoption of NGS for oncology, rare disease, reproductive health, and infectious disease diagnostics. Rising implementation of precision medicine, expanding reimbursement support, and growing demand for high-throughput genomic testing are accelerating segment growth.

By Type (Service) (Sequencing Services (Exome & Targeted Resequencing and Custom Panels, RNA Sequencing, De Novo Sequencing, Chip Sequencing, Whole Genome Sequencing, Methyl Sequencing, Other Sequencing Services), Presequencing Services, (Library Preparation & Target Enrichment, Sample Preparation, Quality Control), Bioinformatics & Data Analysis Services (Data Analysis, Data Visualization & Interpretation, Data Storage & Management Services), NGS Platform Services )

The Sequencing Services segment held the largest share of the Next-generation Sequencing Library Preparation Market, driven by increasing outsourcing of sequencing workflows by pharmaceutical companies, biotechnology firms, academic institutions, and clinical laboratories. The availability of cost-effective, high-throughput sequencing capabilities and advanced technical expertise continues to strengthen demand for outsourced sequencing services.

The Bioinformatics & Data Analysis Services segment is expected to witness the fastest growth during the forecast period, fueled by the rapid expansion of genomic datasets and increasing demand for accurate sequence interpretation. Growing adoption of AI-powered analytics, cloud computing, and integrated genomic data management solutions is accelerating demand across research and clinical applications.

By Workflow (Service) (Sequencing Services, Presequencing Services, Data Analysis Services)

The Sequencing Services segment accounted for the largest share of the Next-generation Sequencing Library Preparation Market due to the growing outsourcing of sequencing projects by pharmaceutical companies, biotechnology firms, academic institutions, and clinical laboratories. High-throughput sequencing capabilities, reduced capital investment, and access to specialized expertise continue to drive the segment's market leadership.

The Data Analysis Services segment is projected to register the fastest growth during the forecast period, driven by the increasing complexity and volume of genomic data generated through NGS. Rising demand for cloud-based bioinformatics platforms, AI-assisted genomic interpretation, and comprehensive data management solutions is significantly accelerating adoption across research and clinical laboratories.

By End User (Service) (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Laboratories, Other End Users)

The Academic & Research Institutes segment held the largest share of the Next-generation Sequencing Library Preparation Market, driven by extensive genomic research, government-funded sequencing initiatives, and increasing collaborations with biotechnology and pharmaceutical companies. Continuous investments in life sciences research and growing adoption of NGS across universities and research centers continue to support segment dominance.

The Hospitals & Clinical Laboratories segment is anticipated to witness the fastest growth during the forecast period, fueled by expanding clinical adoption of NGS for oncology, rare disease diagnosis, infectious disease testing, and reproductive health screening. Increasing implementation of precision medicine and demand for rapid, high-quality genomic testing are accelerating the utilization of outsourced NGS services.

Market Regional Insights:

Next-generation Sequencing Library Preparation Market Regional Analysis and Forecast, 2022–2035 (US$ Million)

By Geography

2022

2025

2035

North America

XX

967.8

3227.5

US

XX

896.1

XX

Canada

XX

71.6

XX

Europe

XX

536.4

1870

Germany

XX

109.9

XX

UK

XX

68.6

XX

France

XX

83.6

XX

Italy

XX

46.1

XX

Spain

XX

43.9

XX

Switzerland

XX

16.6

XX

Netherlands

XX

11.2

XX

Rest of Europe

XX

156.1

XX

Asia Pacific

XX

472

2269.2

China

XX

197.8

XX

India

XX

35.8

XX

Japan

XX

74.5

XX

South Korea

XX

67.5

XX

Singapore

XX

16.9

XX

Australia

XX

24.5

XX

Thailand

XX

6.1

XX

Malaysia

XX

11.8

XX

Philippines

XX

9.4

XX

Indonesia

XX

7.5

XX

Rest of Asia Pacific

XX

19.8

XX

Middle East & Africa

XX

103

381.8

Saudi Arabia

XX

33.7

XX

United Arab Emirates

XX

26.6

XX

South Africa

XX

15.5

XX

Egypt

XX

8.4

XX

Israel

XX

7.4

XX

Rest of MEA

XX

11.1

XX

Latin America

XX

66.5

262.1

Brazil

XX

21.8

XX

Mexico

XX

15.6

XX

Argentina

XX

7

XX

Chile

XX

5.7

XX

Colombia

XX

3.4

XX

Peru

XX

2.8

XX

Rest of LA

XX

9.9

XX

North America Next-generation Sequencing Library Preparation Market Analysis:

North America Next-generation Sequencing Library Preparation market held the largest share of 45.1% of the global market in 2025 and was valued at approximately USD 967.8 million. Market growth is supported by widespread clinical NGS adoption, strong genomics funding, increasing companion diagnostics, and advanced research infrastructure across healthcare and life sciences sectors.

Market Intelligence Overview (Historical, Current, Forecast):

  • 2025 North America Next-generation Sequencing Library Preparation Market Size: USD 967.8 Million
  • 2035 North America Next-generation Sequencing Library Preparation Market Size: USD 3227.5 million
  • North America Next-generation Sequencing Library Preparation CAGR (2026-2033): 12.8%

Drivers

• Expanding Precision Medicine Programs

• Strong Clinical Genomics Funding

• Rising Oncology Sequencing Demand

• Advanced Multi-omics Research Infrastructure

Restraints

• High Library Preparation Kit Costs

• Complex Regulatory Validation Requirements

• Skilled Workforce Shortage in Genomics Laboratories

• Sample Preparation Workflow Complexity

Opportunities

• AI-Integrated Library Preparation Platforms

• Decentralized Clinical Sequencing Expansion

United State Next-generation Sequencing Library Preparation Market Analysis:

The U.S. accounted for the dominant share within North America and represented approximately 92.6% of the regional market in 2025. Market growth is fueled by population-scale genome initiatives, growing precision oncology applications, increasing pharmaceutical R&D investments, and expanding adoption of automated NGS library preparation workflows.

Drivers

• Growing Population-Scale Genome Initiatives

• Increasing Companion Diagnostics Adoption

• Strong Biopharmaceutical R&D Investments

• Broad Adoption of High-Throughput Sequencing

Restraints

• Reimbursement Variability for NGS Tests

• Stringent Laboratory Compliance Standards

• High Instrument Maintenance Expenses

• Data Interpretation Bottlenecks

Opportunities

• Automated Library Preparation in Clinical Labs

• Expansion of Liquid Biopsy Testing

Canada Next-generation Sequencing Library Preparation Market Analysis:

Canada represented approximately 7.4% of the North American market in 2025 and was valued at around USD 71.6 million. Market growth is driven by government-supported genomics programs, expanding rare disease research, increasing academic sequencing activities, and growing investments in precision healthcare infrastructure.

Drivers

•Federal Investment in Genomic Innovation

• Expansion of Rare Disease Sequencing Programs

• Growth of Academic Sequencing Centers

• Rising Public Health Genomics Projects

Restraints

• Limited Commercial Laboratory Density

• Provincial Funding Disparities

• Dependence on Imported Sequencing Reagents

• Remote Sample Logistics Challenges

Opportunities

• Indigenous Genomics Research Initiatives

• Cross-Border Precision Medicine Collaborations

Europe Next-generation Sequencing Library Preparation Market Analysis:

Europe accounted for approximately 25% of the global Next-generation Sequencing Library Preparation market in 2025 and was valued at nearly USD 536.4 million. Market growth is supported by expanding precision medicine initiatives, increasing cancer genomic profiling, strong collaborative research programs, and rising investments in clinical sequencing technologies.

Market Intelligence Overview (Historical, Current, Forecast):

  • 2025 Europe Next-generation Sequencing Library Preparation Market Size: USD 536.4 Million
  • 2035 Europe Next-generation Sequencing Library Preparation Market Size: USD 1870 million
  • Europe Next-generation Sequencing Library Preparation CAGR (2026-2033): 13.3%

Drivers

• EU Support for Genomic Research Networks

• Increasing Cancer Molecular Profiling

• Growing Translational Research Programs

• Expansion of Personalized Healthcare

Restraints

• Fragmented Regulatory Landscape Across Countries

• Diverse Reimbursement Policies

• Cross-Border Data Governance Challenges

• Rising Research Operational Costs

Opportunities

• Pan-European Genomics Partnerships

• Sustainable Library Preparation Technologies

United Kingdom Next-generation Sequencing Library Preparation Market Analysis

The UK represented approximately 12.8% of the European market in 2025 and was valued at nearly USD 68.6 million. Market growth is driven by advanced molecular diagnostics, increasing translational genomics research, expanding biotechnology innovation, and strong adoption of automated sequencing laboratory solutions.

Drivers

• National Genomic Medicine Strategy

• Expansion of Whole Genome Sequencing Services

• Strong Academic Research Ecosystem

• Increasing NHS Genomic Testing Adoption

Restraints

• NHS Budgetary Constraints

• Procurement Delays for Advanced Technologies

• Workforce Capacity Challenges

• Regulatory Transition After Brexit

Opportunities

• Pharmacogenomics Implementation

• Genomics-Based Preventive Healthcare

GermanyNext-generation Sequencing Library Preparation Market Analysis

Germany accounted for approximately 20.5% of the European market in 2025 and was valued at around USD 109.9 million. Market growth is fueled by national genome sequencing programs, expanding NHS genomic services, increasing clinical research activities, and growing demand for precision medicine applications.

Drivers

• Expanding Precision Oncology Trials

• Strong Molecular Diagnostics Industry

• Advanced Biotechnology Manufacturing Base

• Government Support for Translational Medicine

Restraints

• Strict Clinical Validation Expectations

• High Laboratory Accreditation Costs

• Limited Skilled Bioinformatics Workforce

• Rising Energy Costs for Research Facilities

Opportunities

• Automation in Clinical Sequencing Laboratories

• Industrial Genomics Applications

FranceNext-generation Sequencing Library Preparation Market Analysis

The France represented approximately 15.6% of the European market in 2025 and was valued at nearly USD 83.6 million. Market growth is supported by government genomics investments, increasing oncology biomarker testing, expanding public research institutions, and rising adoption of next-generation sequencing technologies.

Drivers

• National Genomic Medicine Investments

• Growth of Oncology Biomarker Testing

• Expanding Public Research Institutes

• Increasing Adoption of Clinical Sequencing

Restraints

• Slow Hospital Technology Procurement

• Limited Private Sequencing Capacity

• Complex Reimbursement Approval Processes

• Regional Infrastructure Gaps

Opportunities

• Expansion of Infectious Disease Genomics

• Public-Private Sequencing Collaborations

ItalyNext-generation Sequencing Library Preparation Market Analysis

Italy accounted for approximately 8.6% of the European market in 2025 and was valued at around USD 46.1 million. Market growth is driven by increasing hereditary disease diagnostics, expanding university genomics research, rising clinical sequencing demand, and continuous investments in molecular medicine.

Drivers

• Rising Demand for Hereditary Disease Testing

• Strengthening Biomedical Research Programs

• Expansion of University Sequencing Centers

• Increasing Clinical Research Activities

Restraints

• Uneven Regional Genomics Infrastructure

• Budget Constraints in Public Hospitals

• Low Laboratory Automation Levels

• Limited Access to Advanced Library Preparation Systems

Opportunities

• Southern Italy Genomics Expansion

• Precision Medicine Research Grants

SpainNext-generation Sequencing Library Preparation Market Analysis

The Spain represented approximately 8.2% of the European market in 2025 and was valued at nearly USD 43.9 million. Market growth is supported by expanding biomedical research, increasing precision oncology adoption, rising rare disease diagnostics, and growing investments in genomic healthcare infrastructure.

Drivers

• Expanding National Cancer Research Programs

• Increasing Genomic Diagnostics Adoption

• Growth of Biomedical Innovation Clusters

• Rising Rare Disease Research

Restraints

• Public Healthcare Budget Limitations

• Dependence on Imported Sequencing Consumables

• Laboratory Capacity Imbalances

• Lengthy Technology Adoption Cycles

Opportunities

• Digital Genomics Infrastructure Development

• Clinical Trial Sequencing Services

Switzerland Next-generation Sequencing Library Preparation Market Analysis

Switzerland accounted for approximately 3.1% of the European market in 2025 and was valued at around USD 16.6 million. Market growth is fueled by strong pharmaceutical innovation, expanding translational genomics research, increasing clinical sequencing applications, and continuous development of advanced molecular diagnostic technologies.

Drivers

• World-Class Life Sciences Research

• Strong Pharmaceutical Innovation Ecosystem

• High Investment in Translational Genomics

• Advanced Clinical Laboratory Standards

Restraints

• Premium Cost of Genomic Services

• Small Domestic Testing Volume

• Stringent Quality Assurance Requirements

• High Skilled Labor Costs

Opportunities

• Biopharma Sequencing Partnerships

• Advanced Single-Cell Genomics Research

Netherlands Next-generation Sequencing Library Preparation Market Analysis

The Netherlands represented approximately 2.1% of the European market in 2025 and was valued at nearly USD 11.2 million. Market growth is driven by integrated genomics programs, expanding multi-center sequencing research, increasing digital healthcare adoption, and growing investments in precision medicine initiatives.

Drivers

• Integrated National Genomics Programs

• Strong Clinical Research Networks

• Increasing Multi-Center Sequencing Studies

• High Digital Healthcare Adoption

Restraints

• Limited Domestic Manufacturing of Sequencing Reagents

• Dependence on Research Grant Funding

• Data Privacy Compliance Complexity

• Competition for Genomics Specialists

Opportunities

• Cloud-Enabled Genomic Workflows

• Precision Agriculture Sequencing Applications

Asia Pacific Next-generation Sequencing Library Preparation Market Analysis

Asia-Pacific accounted for approximately 22% of the global market in 2025 and was valued at nearly USD 472 million. Market growth is supported by expanding genome sequencing initiatives, increasing biotechnology investments, rising clinical NGS adoption, and improving healthcare infrastructure across emerging economies.

Market Intelligence Overview (Historical, Current, Forecast):

  • 2025 Asia Pacific Next-generation Sequencing Library Preparation Market Size: USD 472 Million
  • 2035 Asia Pacific Next-generation Sequencing Library Preparation Market Size: USD 2269.2 million
  • Asia Pacific Next-generation Sequencing Library Preparation CAGR (2026-2033): 17%

Drivers

• Rapid Expansion of National Genome Sequencing Programs

• Growing Investments in Precision Medicine Infrastructure

• Rising Demand for Clinical NGS Testing

• Increasing Regional Biopharmaceutical Innovation

Restraints

•Uneven Genomics Infrastructure Across Countries

• High Dependence on Imported Library Preparation Reagents

• Limited Standardization of NGS Workflows

• Shortage of Experienced Genomic Scientists

Opportunities

•Expansion of Regional Sequencing Manufacturing

•AI-Based Genomic Data Integration

China Next-generation Sequencing Library Preparation Market Analysis

China represented approximately 41.9% of the Asia-Pacific market in 2025 and was valued at around USD 197.8 million. Market growth is fueled by government-backed genomics programs, expanding domestic sequencing capabilities, increasing oncology testing, and rapid advancements in biotechnology manufacturing.

Drivers

• Government Support for Genomic Technology Localization

• Expanding Domestic Sequencing Platform Manufacturing

• Increasing Oncology Genomic Screening

• Growth of Large-Scale Population Genomics Projects

Restraints

• Export Restrictions on Critical Sequencing Components

• Regulatory Approval Complexity for Clinical Assays

• Intellectual Property Challenges

• Variability in Laboratory Quality Standards

Opportunities

• Development of Indigenous Library Preparation Kits

• Expansion of Multi-omics Clinical Research

India Next-generation Sequencing Library Preparation Market Analysis:

India accounted for approximately 7.6% of the Asia-Pacific market in 2025 and was valued at nearly USD 35.8 million. Market growth is driven by expanding genomics research, increasing molecular diagnostics adoption, rising government healthcare initiatives, and growing biotechnology startup investments.

Drivers

• Rising Genomic Medicine Initiatives

• Growing Number of NGS Service Laboratories

• Increasing Rare Disease Diagnosis Programs

• Expansion of Biotechnology Startup Ecosystem

Restraints

• Limited Reimbursement for Genomic Diagnostics

• Inadequate Rural Genomics Infrastructure

• High Cost of Imported Sequencing Consumables

• Shortage of Certified Molecular Geneticists

Opportunities

• Local Manufacturing of NGS Reagents

• Government-Supported Precision Healthcare Programs

Japan Next-generation Sequencing Library Preparation Market Analysis

Japan represented approximately 15.8% of the Asia-Pacific market in 2025 and was valued at around USD 74.5 million. Market growth is supported by precision medicine initiatives, increasing long-read sequencing adoption, advanced clinical research infrastructure, and growing demand for companion diagnostics.

Drivers

• Strong Demand for Companion Diagnostic Testing

• Advanced Clinical Research Infrastructure

• Increasing Adoption of Long-Read Sequencing

• Government Support for Genomic Healthcare

Restraints

• Aging Laboratory Workforce

• High Validation Standards for Clinical Library Preparation

• Elevated Operational Costs in Research Institutions

• Conservative Adoption of Emerging Technologies

Opportunities

• Single-Cell Sequencing Innovation

• Expansion of Regenerative Medicine Genomics

South Korea Next-generation Sequencing Library Preparation Market Analysis

South Korea represented approximately 14.3% of the Asia-Pacific market in 2025 and was valued at around USD 67.5 million. Market growth is fueled by government precision medicine programs, expanding biotechnology innovation, increasing cancer genomics research, and rapid adoption of advanced sequencing technologies.

Drivers

• Strong Government Investment in Precision Medicine

• Expanding Biopharmaceutical Clinical Trials

• Advanced Digital Healthcare Ecosystem

• Growth of Cancer Genome Research

Restraints

• Limited Domestic Availability of Specialized Consumables

• Dependence on Premium Imported Instruments

• Competitive Research Funding Environment

• Regulatory Complexity for Clinical Sequencing

Opportunities

• Smart Laboratory Automation Solutions

• Integration of Genomics with Digital Health Platforms

Singapore Next-generation Sequencing Library Preparation Market Analysis:

Singapore accounted for approximately 3.6% of the Asia-Pacific market in 2025 and was valued at nearly USD 16.9 million. Market growth is driven by strong biomedical research funding, international genomics collaborations, expanding translational medicine programs, and increasing clinical sequencing capabilities.

Drivers

• Regional Hub for Biomedical Research

• High Government Funding for Genomics Innovation

• Strong International Research Collaborations

• Expansion of Translational Medicine Programs

Restraints

• Limited Domestic Patient Population

• High Laboratory Operating Costs

• Dependence on Global Supply Chains

• Talent Competition in Life Sciences

Opportunities

• Asia-Pacific Genomics Collaboration Hub

• Development of Clinical Sequencing Centers of Excellence

Australia Next-generation Sequencing Library Preparation Market Analysis

Australia represented approximately 5.2% of the Asia-Pacific market in 2025 and was valued at around USD 24.5 million. Market growth is supported by national genomic healthcare initiatives, increasing cancer diagnostics, expanding academic sequencing research, and growing investments in precision medicine.

Drivers

• National Investment in Genomic Healthcare

• Growing Demand for Precision Cancer Diagnostics

• Expansion of Academic Sequencing Facilities

• Increasing Public Health Genomics Research

Restraints

• Geographic Challenges in Sample Transportation

• Limited Local Manufacturing of Sequencing Reagents

• High Cost of Clinical Genomic Services

• Workforce Shortages in Regional Areas

Opportunities

•Expansion of Rural Genomic Testing Networks

• Indigenous Population Genomics Research

Thailand Next-generation Sequencing Library Preparation Market Analysis

Thailand represented approximately 1.3% of the Asia-Pacific market in 2025 and was valued at around USD 6.1 million. Market growth is driven by government healthcare modernization, increasing molecular diagnostics adoption, expanding biotechnology research, and rising investments in genomic medicine.

Drivers

• Government Focus on Genomic Medicine Development

• Expansion of Medical Research Institutions

• Rising Clinical Adoption of NGS Technologies

• Growth of Biotechnology Investments

Restraints

• Limited Advanced Sequencing Infrastructure

• Dependence on Imported Library Preparation Products

• Budget Constraints in Public Hospitals

• Insufficient Bioinformatics Expertise

Opportunities

• Medical Tourism Genomics Services

• Regional Clinical Research Collaborations

Malaysia Next-generation Sequencing Library Preparation Market Analysis:

Malaysia accounted for approximately 2.5% of the Asia-Pacific market in 2025 and was valued at nearly USD 11.8 million. Market growth is fueled by expanding biotechnology research, increasing personalized medicine adoption, growing university genomics programs, and improving molecular diagnostics capabilities.

Drivers

• Growing Molecular Diagnostics Market

• Increasing Investment in Biotechnology Research

• Expansion of University Genomics Programs

• Rising Demand for Personalized Medicine

Restraints

• Limited High-Throughput Sequencing Facilities

• Imported Reagent Price Volatility

• Inconsistent Research Funding

• Shortage of Specialized Laboratory Personnel

Opportunities

• Halal Pharmaceutical Genomics Research

• Public-Private Genomics Innovation Partnerships

Philippines Next-generation Sequencing Library Preparation Market Analysis

Philippines represented approximately 2% of the Asia-Pacific market in 2025 and was valued at around USD 9.4 million. Market growth is supported by strengthening disease surveillance programs, increasing molecular diagnostics adoption, expanding healthcare modernization, and rising investments in genomic research.

Drivers

• Expansion of National Disease Surveillance Programs

• Growing Adoption of Molecular Diagnostics

• Rising Government Healthcare Modernization

• Increasing Academic Genomics Research

Restraints

• Limited Clinical Sequencing Capacity

• High Dependence on External Testing Services

• Budget Limitations for Advanced Diagnostics

• Lack of Standardized Genomics Training

Opportunities

• Expansion of Infectious Disease Sequencing

• Development of Local Reference Genomic Databases

Indonesia Next-generation Sequencing Library Preparation Market Analysis

Indonesia represented approximately 1.6% of the Asia-Pacific market in 2025 and was valued at around USD 7.5 million. Market growth is driven by increasing infectious disease genomics, expanding biotechnology initiatives, improving healthcare infrastructure, and growing adoption of precision medicine technologies.

Drivers

• Growing Demand for Infectious Disease Genomics

• Increasing Healthcare Infrastructure Development

• Expansion of National Biotechnology Programs

• Rising Interest in Precision Medicine

Restraints

• Archipelagic Sample Logistics Challenges

• Limited Access to Advanced Sequencing Facilities

• Dependence on Imported NGS Consumables

• Low Awareness of Clinical Genomics

Opportunities

• Population Diversity Genomics Research

• Government Expansion of Genomic Laboratory Networks

Middle East & Africa Next-generation Sequencing Library Preparation Market Analysis

Middle East & Africa accounted for approximately 4.8% of the global market in 2025 and was valued at nearly USD 103 million. Market growth is supported by national genomics initiatives, increasing precision healthcare investments, expanding genetic disease diagnostics, and strengthening molecular research capabilities.

Market Intelligence Overview (Historical, Current, Forecast):

  • 2025 Middle East & Africa Next-generation Sequencing Library Preparation Market Size: USD 103 Million
  • 2035 Middle East & Africa Next-generation Sequencing Library Preparation Market Size: USD 381.8 million
  • Middle East & Africa Next-generation Sequencing Library Preparation CAGR (2026-2033): 14%

Drivers

• Expanding National Genomics Strategies

• Growing Investment in Precision Healthcare

• Rising Prevalence of Genetic Disorders

• Increasing Public Health Genomic Surveillance

Restraints

• Limited Regional Sequencing Infrastructure

• Dependence on Imported Library Preparation Reagents

• Shortage of Genomics Specialists

• Uneven Healthcare Funding Across Countries

Opportunities

• Establishment of Regional Genomics Centers

• International Genomics Research Partnerships

Saudi Arabia Next-generation Sequencing Library Preparation Market Analysis:

Saudi Arabia accounted for approximately 32.8% of the Middle East market in 2025 and was valued at nearly USD 33.7 million. Market growth is driven by Vision 2030 healthcare transformation, expanding national genome programs, increasing inherited disease screening, and growing biotechnology investments.

Drivers

• Vision 2030 Healthcare Transformation

• National Human Genome Program Expansion

• Rising Demand for Inherited Disease Screening

• Government Investment in Biotechnology Parks

Restraints

• Limited Domestic Manufacturing of NGS Consumables

• Dependence on Foreign Technical Expertise

• High Procurement Costs for Sequencing Systems

• Clinical Validation Capacity Constraints

Opportunities

• Local Production of Genomics Reagents

• Expansion of Precision Oncology Services

United Arab Emirates Next-generation Sequencing Library Preparation Market Analysis

United Arab Emirates represented approximately 25.9% of the Middle East market in 2025 and was valued at around USD 26.6 million. Market growth is fueled by national genome initiatives, increasing precision medicine adoption, expanding biotechnology investments, and growing demand for advanced molecular diagnostics.

Drivers

• Rapid Adoption of Precision Medicine

• Expansion of National Genome Initiatives

• Increasing Investments in Advanced Diagnostics

• Strong Government Support for Biotechnology

Restraints

• Small Domestic Research Population

• High Cost of Specialized Genomics Laboratories

• Dependence on Imported Sequencing Consumables

• Talent Retention Challenges

Opportunities

• Regional Hub for Clinical Genomics

• AI-Enabled Personalized Healthcare Solutions

South Africa Next-generation Sequencing Library Preparation Market Analysis

South Africa represented approximately 15.1% of the Middle East market in 2025 and was valued at around USD 15.5 million. Market growth is supported by expanding infectious disease genomics, increasing academic sequencing research, growing cancer genomics studies, and strengthening healthcare research investments.

Drivers

• Growing Infectious Disease Genomics Research

• Expansion of Academic Sequencing Facilities

• Increasing Government Health Research Funding

• Rising Cancer Genomics Studies

Restraints

• Limited Access to High-End Sequencing Platforms

• Public Healthcare Budget Constraints

• Inadequate Rural Genomic Testing Access

• Supply Chain Delays for Laboratory Reagents

Opportunities

• African Population Genomics Studies

• International Clinical Research Collaborations

Egypt Next-generation Sequencing Library Preparation Market Analysis:

Egypt accounted for approximately 8.2% of the Middle East & Africa market in 2025 and was valued at nearly USD 8.4 million. Market growth is driven by healthcare modernization, increasing molecular biology research, expanding genetic disease diagnostics, and growing investments in academic genomics programs.

Drivers

• Expanding National Healthcare Modernization

• Increasing Academic Molecular Research

• Rising Demand for Genetic Disease Diagnostics

• Growth in University Research Laboratories

Restraints

• Limited Funding for Advanced Sequencing Projects

• Dependence on Imported Laboratory Kits

• Low Clinical Adoption of Precision Medicine

• Limited Bioinformatics Infrastructure

Opportunities

• Expansion of Prenatal Genomic Testing

• Regional Biotechnology Investment Programs

Israel Next-generation Sequencing Library Preparation Market Analysis

Israel represented approximately 7.2% of the Middle East and Africa market in 2025 and was valued at around USD 7.4 million. Market growth is fueled by advanced biotechnology innovation, strong precision medicine research, increasing clinical genomics adoption, and robust investments in life sciences.

Drivers

• Strong Precision Medicine Research Ecosystem

• Advanced Biotechnology Innovation

• High Clinical Adoption of Genomic Diagnostics

• Robust Venture Capital Support for Genomics

Restraints

• Rising Cost of Genomic Research Activities

• Limited Domestic Market Size

• Increasing Data Privacy Compliance Requirements

• Competition for Skilled Researchers

Opportunities

• Development of Novel Library Preparation Chemistries

• Expansion of Multi-omics Drug Discovery

Latin America Next-generation Sequencing Library Preparation Market Analysis

Latin America accounted for approximately 3.1% of the global market in 2025 and was valued at around USD 66.5 million. Market growth is supported by increasing molecular diagnostics adoption, expanding genomics research collaborations, rising cancer diagnostics demand, and improving healthcare infrastructure investments.

Market Intelligence Overview (Historical, Current, Forecast):

  • 2025 Latin America Next-generation Sequencing Library Preparation Market Size: USD 66.5 Million
  • 2035 Latin America Next-generation Sequencing Library Preparation Market Size: USD 262.1 million
  • Latin America Next-generation Sequencing Library Preparation CAGR (2026-2033): 14.7%

Drivers

• Increasing Government Investment in Molecular Diagnostics

• Growing Burden of Cancer and Rare Diseases

• Expanding Genomic Research Collaborations

• Rising Adoption of Clinical NGS Technologies

Restraints

• Limited Access to High-Throughput Sequencing Facilities

• Economic Instability Affecting Research Spending

• Heavy Dependence on Imported Reagents

• Regulatory Heterogeneity Across Countries

Opportunities

• Regional Precision Medicine Programs

• Expansion of Local Sequencing Service Providers

Brazil Next-generation Sequencing Library Preparation Market Analysis:

Brazil accounted for approximately 32.9% of the Latin America market in 2025 and was valued at nearly USD 21.8 million. Market growth is driven by expanding genomics research programs, increasing precision oncology adoption, strong agricultural genomics applications, and growing clinical sequencing activities.

Drivers

• Expanding National Genomic Research Programs

• Strong Agricultural Genomics Applications

• Growing Precision Oncology Adoption

• Increasing Clinical Research Activities

Restraints

• High Import Duties on Laboratory Equipment

• Regional Healthcare Infrastructure Disparities

• Complex Regulatory Approval Procedures

• Currency Fluctuations Affecting Reagent Costs

Opportunities

• Local Manufacturing of Library Preparation Kits

• Large-Scale Population Genomics Projects

Mexico Next-generation Sequencing Library Preparation Market Analysis:

Mexico accounted for approximately 23.5% of the Latin America market in 2025 and was valued at nearly USD 15.6 million. Market growth is fueled by expanding clinical molecular diagnostics, increasing pharmaceutical research, growing genomics programs, and rising investments in precision healthcare.

Drivers

• Increasing Public Health Genomics Programs

• Growth of Clinical Molecular Diagnostics

• Rising Pharmaceutical Research Investments

• Expanding University Genomics Centers

Restraints

• Limited Reimbursement for Advanced Genomic Testing

• Dependence on Imported Sequencing Technologies

• Uneven Laboratory Capacity

• Shortage of Clinical Genomics Professionals

Opportunities

• Cross-Border Genomics Research Initiatives

• Expansion of Companion Diagnostic Testing

Argentina Next-generation Sequencing Library Preparation Market Analysis

Argentina represented approximately 10.6% of the Latin America market in 2025 and was valued at around USD 7 million. Market growth is supported by strong biomedical research, increasing rare disease diagnostics, expanding government science funding, and growing precision medicine initiatives.

Drivers

• Strong Biomedical Research Institutions

• Increasing Rare Disease Research

• Rising Adoption of Precision Diagnostics

• Expansion of Government Science Funding

Restraints

• Economic Volatility Affecting Laboratory Investments

• Imported Reagent Supply Challenges

• Limited Commercial Sequencing Infrastructure

• Brain Drain of Genomics Experts

Opportunities

• Academic-Industry Genomics Partnerships

• Expansion of Translational Medicine Research

Chile Next-generation Sequencing Library Preparation Market Analysis

Chile represented approximately 8.6% of the Latin America market in 2025 and was valued at around USD 5.7 million. Market growth is driven by expanding biomedical innovation, increasing precision oncology programs, strengthening scientific research, and growing adoption of genomic diagnostic technologies.

Drivers

• Growing Investment in Biomedical Innovation

• Expansion of Precision Oncology Programs

• Increasing Government Support for Scientific Research

• Rising Genomic Disease Surveillance

Restraints

• Limited Domestic Production of Sequencing Consumables

• Small Clinical Sequencing Market

• High Cost of Advanced Molecular Diagnostics

• Dependence on International Suppliers

Opportunities

• National Biobank Development

• Precision Medicine Research Collaborations

Colombia Next-generation Sequencing Library Preparation Market Analysis:

Colombia accounted for approximately 5.2% of the Latin America market in 2025 and was valued at nearly USD 3.4 million. Market growth is fueled by expanding molecular diagnostics infrastructure, increasing cancer genomic testing, growing university research activities, and rising healthcare technology investments.

Drivers

• Expanding Molecular Diagnostics Infrastructure

• Rising Demand for Cancer Genomic Testing

• Growth in University Research Programs

• Increasing Healthcare Technology Investments

Restraints

• Limited Genomics Laboratory Network

• Budget Constraints in Public Healthcare

• Dependence on Imported NGS Products

• Regulatory Delays for New Technologies

Opportunities

• Expansion of Clinical Sequencing Services

• Development of National Genomic Databases

Peru Next-generation Sequencing Library Preparation Market Analysis

Peru represented approximately 4.3% of the Latin America market in 2025 and was valued at around USD 2.8 million. Market growth is supported by expanding public health genomics, increasing genetic disease research, strengthening clinical laboratory capabilities, and growing international genomics collaborations.

Drivers

• Increasing Government Focus on Genetic Disease Research

• Growth of Public Health Genomics

• Rising Academic Collaboration in Molecular Biology

• Expanding Clinical Laboratory Capabilities

Restraints

• Limited Access to Advanced Sequencing Centers

• Shortage of Specialized Genomics Workforce

• High Cost of Imported Sequencing Kits

• Inadequate Bioinformatics Capacity

Opportunities

• Genomic Research on Indigenous Populations

• International Funding for Genomics Infrastructure

Next-generation Sequencing Library Preparation Market Key Players:

Company

Share

Illumina, Inc.

21.8%

Thermo Fisher Scientific Inc.

14.2%

Agilent Technologies, Inc.

10.8%

F. Hoffmann-La Roche Ltd.

8.3%

Danaher Corp.

7.3%

The global Next-generation Sequencing Library Preparation Market is moderately consolidated, with the top five players accounting for approximately 62.4% of the global market. Illumina, Thermo Fisher Scientific, Agilent Technologies, Roche, and Danaher maintain leadership through comprehensive library preparation portfolios, automation platforms, strategic acquisitions, and strong partnerships with clinical, pharmaceutical, and academic research institutions.

Next-generation Sequencing Library Preparation Market Recent Developments

  • In February 2025, Roche introduced its proprietary Sequencing by Expansion (SBX) technology, a next-generation sequencing platform designed to deliver ultra-rapid, scalable, and highly accurate sequencing. The innovation reduces sample-to-genome processing time from days to hours, supporting faster genomic research and clinical applications.
  • In April 2025, Oxford Nanopore Technologies and Cepheid announced a strategic collaboration to develop an automated end-to-end nanopore sequencing workflow by integrating the GeneXpert system for sample and library preparation with Oxford Nanopore's sequencing platform, enabling faster in-house infectious disease analysis.
  • In January 2025, Thermo Fisher Scientific introduced Olink Reveal, an affordable NGS-based high-plex proteomics solution that measures approximately 1,000 human proteins. The platform enables simplified biomarker discovery with reduced costs and seamless integration into existing next-generation sequencing workflows, supporting translational and inflammation research.

Next-generation Sequencing Library Preparation Market Regulatory Landscape Analysis :

  • FDA, EMA, PMDA and NMPA regulatory approvals
  • IVDR, IVDD and CLIA compliance assessment
  • Quality management and laboratory accreditation overview
  • Regulatory impact on clinical NGS commercialization

Next-generation Sequencing Library Preparation Market Patent & IP Landscape Analysis :

  • Patent filing and expiry trend analysis
  • Intellectual property competitiveness assessment
  • Licensing, technology transfer and collaboration analysis
  • Innovation hubs and emerging patent clusters

Next-generation Sequencing Library Preparation Market Segmentations:

Our research framework strategically segments the Next-generation Sequencing Library Preparation market by Offerings, Application, Technology (Platforms), Type (Products), Workflow (Product), End User (Products), Type (Services), Workflow (Services), End User (Services) and key regional markets

By Offerings

  • Products
  • Services

By Application

  • Diagnostics
  • Cancer Diagnostics
  • Infectious Disease Diagnostics
  • Reproductive Health Diagnostics
  • Other Diagnostic Applications
  • Drug Discovery & Development
  • Pharmacogenomics
  • Other Drug Discovery & Development Applications
  • Agriculture & Animal Research
  • Other Applications

By Technology (Platforms)

  • Sequencing By Synthesis
  • Ion Semiconductor Sequencing
  • Single-Molecule Real Time Sequencing
  • Nanopore Sequencing
  • Other Sequencing Technologies

By Type (Products)

  • Consumables
  • Library Preparation Kits & Reagents
  • Sequencing Kits & Reagents
  • Other Consumables
  • Platforms
  • Sequencing Platforms
  • Library Preparation Platforms
  • Bioinformatics Tools
  • Data Analysis Software & Workbenches
  • Data Visualization Tools
  • Other Bioinformatics Tools

By Workflow (Product)

  • Sequencing
  • Presequencing
  • Data Analysis

By End User (Products)

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Clinical & Diagnostics Laboratories
  • Other End Users

By Type (Services)

  • Sequencing Services
  • Exome & Targeted Resequencing and Custom Panels
  • RNA Sequencing
  • De Novo Sequencing
  • Chip Sequencing
  • Whole Genome Sequencing
  • Methyl Sequencing
  • Other Sequencing Services
  • Presequencing Services
  • Library Preparation & Target Enrichment
  • Sample Preparation
  • Quality Control
  • Bioinformatics & Data Analysis Services
  • Data Analysis
  • Data Visualization & Interpretation
  • Data Storage & Management Services
  • NGS Platform Services

By Workflow (Services)

  • Sequencing Services
  • Presequencing Services
  • Data Analysis Services

By End User (Services)

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinical Laboratories
  • Other End Users

By Region & Country

North America

  • USA
  • Canada

Europe

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Switzerland
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia
  • Thailand
  • Malaysia
  • Philippines
  • Indonesia
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
  • Peru
  • Rest of LA

Middle East & Africa

  • Saudi Arabia
  • United Arab Emirates
  • South Africa
  • Egypt
  • Israel
  • Rest of MEA

Top Players

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corp.
  • QIAGEN
  • Revvity
  • Eurofins Scientific
  • PacBio
  • Oxford Nanopore Technologies plc
  • Takara Bio Inc.
  • BGI Group
  • BD
  • 10X Genomics
  • Promega Corp.
  • LGC Limited
  • WuXi Biologics
  • Tecan Trading AG
  • Twist Bioscience
  • Azenta US Inc.
  • MGI Tech Co. Ltd.
  • Novogene Co., Ltd.
  • New England Biolabs
  • Genscript
  • Psomagen
  • Zymo Research Corp.n
  • Hamilton Company
  • Neogenomics Laboratories
  • Fulgent Genetics
  • SD Biosensor, Inc.

Key Report Attributes

Details

Years Considered

2022 to 2035

Market Size 2025

USD 2145.9 Million

Market Size 2035

USD 8010.9 Million

Historical CAGR% (Growth rate)

12.3% from 2022 to 2025

Futuristic CAGR% (Growth rate)

14.08% from 2026 to 2035

Segments Covered

  • By Offerings
  • By Application
  • By Technology (Platforms)
  • By Type (Products)
  • By Workflow (Product)
  • By End User (Products)
  • By Type (Services)
  • By Workflow (Services)
  • By End User (Services)

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

USA; Canada; Germany; United Kingdom; France; Italy; Spain; Switzerland; Netherlands; China; India; Japan; South Korea; Singapore; Australia; Thailand; Malaysia; Philippines; Indonesia; Saudi Arabia; United Arab Emirates; South Africa; Egypt; Israel; Brazil; Mexico; Argentina; Chile; Colombia; Peru

Competitive Landscape Overview

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corp.
  • QIAGEN
  • Revvity
  • Eurofins Scientific
  • PacBio
  • Oxford Nanopore Technologies plc
  • Takara Bio Inc.
  • BGI Group
  • BD
  • 10X Genomics
  • Promega Corp.
  • LGC Limited
  • WuXi Biologics
  • Tecan Trading AG
  • Twist Bioscience
  • Azenta US Inc.
  • MGI Tech Co. Ltd.
  • Novogene Co., Ltd.
  • New England Biolabs
  • Genscript
  • Psomagen
  • Zymo Research Corp.n
  • Hamilton Company
  • Neogenomics Laboratories
  • Fulgent Genetics
  • SD Biosensor, Inc.

Flexible Report Customization

The study can be customized based on geography, segment analysis, company profiling, competitive benchmarking, and strategic insights.

Data Sources

Primary and secondary sources used (Company filings, trade associations, Journals, Annual report, Publications, Surveys, Investor Presentations, and much more.

Related Reports

Next-Generation Sequencing Market

SUMMARY
Book Free Consultation
Segmentation
Segments

By Offerings

  • Products
  • Services

By Application

  • Diagnostics
  • Cancer Diagnostics
  • Infectious Disease Diagnostics
  • Reproductive Health Diagnostics
  • Other Diagnostic Applications
  • Drug Discovery & Development
  • Pharmacogenomics
  • Other Drug Discovery & Development Applications
  • Agriculture & Animal Research
  • Other Applications

By Technology (Platforms)

  • Sequencing By Synthesis
  • Ion Semiconductor Sequencing
  • Single-Molecule Real Time Sequencing
  • Nanopore Sequencing
  • Other Sequencing Technologies

By Type (Products)

  • Consumables
  • Library Preparation Kits & Reagents
  • Sequencing Kits & Reagents
  • Other Consumables
  • Platforms
  • Sequencing Platforms
  • Library Preparation Platforms
  • Bioinformatics Tools
  • Data Analysis Software & Workbenches
  • Data Visualization Tools
  • Other Bioinformatics Tools

By Workflow (Product)

  • Sequencing
  • Presequencing
  • Data Analysis

By End User (Products)

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Clinical & Diagnostics Laboratories
  • Other End Users

By Type (Services)

  • Sequencing Services
  • Exome & Targeted Resequencing and Custom Panels
  • RNA Sequencing
  • De Novo Sequencing
  • Chip Sequencing
  • Whole Genome Sequencing
  • Methyl Sequencing
  • Other Sequencing Services
  • Presequencing Services
  • Library Preparation & Target Enrichment
  • Sample Preparation
  • Quality Control
  • Bioinformatics & Data Analysis Services
  • Data Analysis
  • Data Visualization & Interpretation
  • Data Storage & Management Services
  • NGS Platform Services

By Workflow (Services)

  • Sequencing Services
  • Presequencing Services
  • Data Analysis Services

By End User (Services)

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinical Laboratories
  • Other End Users
Regions and Country
Regions and Country

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of MEA
Key Players
Key Players
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corp.
  • QIAGEN
  • Revvity
  • Eurofins Scientific
  • PacBio
  • Oxford Nanopore Technologies plc
  • Takara Bio Inc.
  • BGI Group
  • BD
  • 10X Genomics
  • Promega Corp.
  • LGC Limited
  • WuXi Biologics
  • Tecan Trading AG
  • Twist Bioscience
  • Azenta US Inc.
  • MGI Tech Co. Ltd.
  • Novogene Co., Ltd.
  • New England Biolabs
  • Genscript
  • Psomagen
  • Zymo Research Corp.n
  • Hamilton Company
  • Neogenomics Laboratories
  • Fulgent Genetics
  • SD Biosensor, Inc.

Next-generation Sequencing Library Preparation Market (2026 to 2035) Related Frequently Asked Questions

The current global market size is USD 2145.9 Million
The market is projected to reach USD 8010.9 Million by 2035.
The market is expected to grow at a CAGR of 14.08% during the forecast period.
Key factors driving the Next-generation Sequencing Library Preparation market growth include expanding precision medicine adoption, increasing genome sequencing initiatives, rising oncology and rare disease testing, and continuous advancements in automated library preparation technologies.
North America accounted for more than 45.1% of the global market share.
Key growth drivers include: • Expanding adoption of precision medicine and personalized healthcare • Increasing genome sequencing initiatives and population genomics projects • Rising demand for oncology, rare disease, and infectious disease testing • Advancements in automated, high-throughput library preparation technologies • Growing investments in genomics research, drug discovery, and multi-omics applications
Diagnostics held the largest market share with approximately 35.2% revenue contribution in 2025.
Sequencing By Synthesis dominated the market with approximately 61.8% share in 2025.
The market is segmented by: • By Offerings • By Application • By Technology (Platforms) • By Type (Products) • By Workflow (Product) • By End User (Products) • By Type (Services) • By Workflow (Services) • By End User (Services)
Products dominated the market with approximately 74.6% share in 2025.

+44 1313818849

sales@brandessenceresearch.com

We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com

JOIN US

INDIA OFFICE

BrandEssence® Market Research and Consulting Pvt ltd.

408B, City Center, Hadapsar, Pune, India 411028

FOLLOW US

Twitter
Facebook
LinkedIn
YouTube

CONTACT US

+44 1313818849 - U.K. OFFICE+91 8975852287 - INDIA OFFICE+91 9158073870 - INDIA OFFICE

© Copyright 2026-27 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®

PaymentModes